Clinical trials of asparaginase in chemotherapy-resistant acute leukemias.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000681:Amylases / Q000032:analysis; D001215:Asparaginase / Q000009:adverse effects / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001780:Blood Coagulation Tests; D002648:Child; D004351:Drug Resistance; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D006801:Humans; D007945:Leukemia, Lymphoid / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D008055:Lipids / Q000097:blood; D008111:Liver Function Tests; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced
D008055:Lipids; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D000681:Amylases; D001215:Asparaginase; D001663:Bilirubin